Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000781336 | SCV000919298 | likely benign | not specified | 2018-07-09 | criteria provided, single submitter | clinical testing | Variant summary: DTNA c.1740G>T alters a non-conserved nucleotide resulting in a synonymous change. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 1.7e-05 in 120892 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.1740G>T in individuals affected with Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Another variant c.1740G>A, causing same synonymous change, has been classified as benign by our laboratory. Based on the evidence outlined above, the variant was classified as likely benign. |
Labcorp Genetics |
RCV003768456 | SCV004626178 | likely benign | Left ventricular noncompaction 1 | 2023-12-17 | criteria provided, single submitter | clinical testing |